We are live on
!
Find out more
Qube Research & Technologies (QRT) Portfolio holdings
AUM
$89.9B
1-Year Est. Return
20.22%
This Fund
S&P 500
This Quarter
Est. Return
+6.68%
1 Year Est. Return
+20.22%
3 Year Est. Return
+42.42%
5 Year Est. Return
+23.97%
10 Year Est. Return
–
AUM
$18.7B
AUM Growth
+$1.89B
(+11%)
Cap. Flow
+$1.31B
Cap. Flow
% of AUM
7.02%
Top 10 Holdings %
Top 10 Hldgs %
10.01%
Holding
3,237
New
779
Increased
845
Reduced
690
Closed
834
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$109M |
| 2 |
Norwegian Cruise Line
NCLH
|
+$105M |
| 3 |
Goldman Sachs
GS
|
+$104M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$101M |
| 5 |
Steel Dynamics
STLD
|
+$99.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$176M |
| 2 |
Coca-Cola
KO
|
+$151M |
| 3 |
Broadcom
AVGO
|
+$146M |
| 4 |
Microsoft
MSFT
|
+$140M |
| 5 |
ExxonMobil
XOM
|
+$137M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.93% |
| 2 | Industrials | 11.65% |
| 3 | Consumer Discretionary | 11.56% |
| 4 | Healthcare | 11.56% |
| 5 | Financials | 11.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Incyte
INCY
$23.5B
| $28.5M | 0.15% |
354,263
-233,711
| -40% | -$17.9M |
|
177
Graphic Packaging
GPK
$3.26B
| $28.3M | 0.15% |
1,271,558
+751,502
| +145% | +$16.5M |
|
178
SS&C Technologies
SSNC
$17.8B
| $28.3M | 0.15% |
542,710
+16,981
| +3% | +$861K |
|
179
Qualcomm
QCOM
$176B
| $28.2M | 0.15% |
256,486
-307,094
| -54% | -$35.9M |
|
180
PUT
Procter & Gamble
PG
$343B
| $28M | 0.15% |
185,000
+75,000
| +68% | +$10.5M |
|
181
Toro Company
TTC
$8.93B
| $28M | 0.15% |
+247,110
| New | +$26.2M |
|
182
Futu Holdings
FUTU
$13.9B
| $28M | 0.15% |
687,870
+458,926
| +200% | +$22.4M |
|
183
Sociedad Química y Minera de Chile
SQM
$19.6B
| $27.8M | 0.15% |
348,625
+152,731
| +78% | +$14.1M |
|
184
Unilever
UL
$131B
| $27.6M | 0.15% |
+487,276
| New | +$26.1M |
|
185
BioMarin Pharmaceuticals
BMRN
$11.5B
| $27.5M | 0.15% |
265,270
+169,933
| +178% | +$16M |
|
186
Nordson
NDSN
$16.5B
| $27.3M | 0.15% |
+115,050
| New | +$26.3M |
|
187
iShares MSCI Emerging Markets ETF
EEM
$28B
| $27.2M | 0.15% |
718,160
+238,479
| +50% | +$8.8M |
|
|
UMPQ
188
DELISTED
Umpqua Holdings Corp
UMPQ
| $27.2M | 0.15% |
1,522,585
+1,246,078
| +451% | +$23.5M |
|
|
CTRA
189
DELISTED
Coterra Energy
CTRA
| $27.1M | 0.15% |
1,102,800
+1,080,514
| +4,848% | +$29.8M |
|
|
190
PUT
Coca-Cola
KO
$354B
| $27M | 0.14% |
425,000
+250,000
| +143% | +$15.1M |
|
191
Colgate-Palmolive
CL
$72.6B
| $27M | 0.14% |
342,376
-296,479
| -46% | -$22.2M |
|
192
Exelixis
EXEL
$13.9B
| $26.8M | 0.14% |
1,670,991
+362,209
| +28% | +$5.91M |
|
193
Voya Financial
VOYA
$8.94B
| $26.7M | 0.14% |
+434,574
| New | +$27.8M |
|
194
Carrier Global
CARR
$57.2B
| $26.6M | 0.14% |
645,896
+320,698
| +99% | +$13M |
|
195
Neurocrine Biosciences
NBIX
$17.7B
| $26.6M | 0.14% |
222,817
+214,655
| +2,630% | +$25.1M |
|
196
Salesforce
CRM
$134B
| $26.6M | 0.14% |
200,433
+4,775
| +2% | +$697K |
|
197
C.H. Robinson
CHRW
$22B
| $26.3M | 0.14% |
286,786
-131,565
| -31% | -$12.5M |
|
198
Builders FirstSource
BLDR
$7.84B
| $25.9M | 0.14% |
399,635
+185,412
| +87% | +$11.6M |
|
199
Camden Property Trust
CPT
$11.3B
| $25.9M | 0.14% |
231,306
+173,616
| +301% | +$19.9M |
|
200
HP
HPQ
$23.5B
| $25.8M | 0.14% |
960,897
+509,791
| +113% | +$14.1M |
|
Similar funds
Qube Research & Technologies (QRT)'s Q4 2022 Portfolio in Review
As of Q4 2022, Qube Research & Technologies (QRT) held 3,237 positions worth $18.7B, up 11% from $16.8B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Qube Research & Technologies (QRT) deployed $1.31B of net new capital in Q4 2022, opening 779 new positions and adding to 845 existing holdings. Its largest new stake was Bristol-Myers Squibb: 1,451,017 shares worth $104M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 21% a quarter earlier, followed by Industrials and Consumer Discretionary.
On the sell side, the largest reduction was Microsoft, an estimated $140M trimmed.
- Qube Research & Technologies (QRT)'s largest Q4 2022 buy was Bristol-Myers Squibb: 1,451,017 shares worth $104M.
- Qube Research & Technologies (QRT) added most to Goldman Sachs in Q4 2022, an estimated $104M increase.
- Qube Research & Technologies (QRT)'s biggest Q4 2022 reduction was Microsoft, cutting an estimated $140M.
- Qube Research & Technologies (QRT) fully exited Chevron in Q4 2022, selling an estimated $176M.
- Qube Research & Technologies (QRT)'s ten largest holdings make up 10% of its $18.7B portfolio in Q4 2022.
- Qube Research & Technologies (QRT) opened 779 new positions and closed 834 in Q4 2022.
- Qube Research & Technologies (QRT)'s portfolio value rose 11% quarter-over-quarter to $18.7B.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2022, filed 14 Feb 2023.